Skip to main content
Clinical Trials/ISRCTN23255677
ISRCTN23255677
Completed
Not Applicable

Deep brain stimulation (DBS) of the nucleus accumbens in treatment-refractory patients with obsessive-compulsive disorder (OCD)

Academic Medical Center (AMC) (The Netherlands)0 sites16 target enrollmentJune 7, 2006

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Obsessive-compulsive disorder (OCD)
Sponsor
Academic Medical Center (AMC) (The Netherlands)
Enrollment
16
Status
Completed
Last Updated
11 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
June 7, 2006
End Date
TBD
Last Updated
11 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Academic Medical Center (AMC) (The Netherlands)

Eligibility Criteria

Inclusion Criteria

  • 1\. Primary diagnosis: OCD (300\.3\) according to Diagnostic and Statistical Manual of Mental Disorders \- Fourth Edition (DSM\-IV) criteria using the mini\-international neuropsychiatric interview (MINI) plus interview as a diagnostic instrument
  • 2\. Illness duration \>5 years
  • 3\. Yale\-Brown obsessive\-compulsive scale (Y\-BOCS) total \>27, measured twice at least two weeks apart
  • 4\. Disabling severity with substantial functional impairment according to the DSM\-IV criterion C and a global assessment of function (GAF) score of \<45
  • 5\. Age 18 \- 65 years
  • 6\. Written informed consent
  • 7\. Able to fully understand the consequences of the procedure (intelligence quotient \[IQ] \>80\)
  • 8\. Dutch speaking and able to answer all study questions
  • 9\. Capable to make his or her own choice without coercion
  • 10\. Treatment refractory is defined as no response or insufficient response (still fulfilling the inclusion criteria) following:

Exclusion Criteria

  • Any of the following unstable physical conditions: Parkinson's disease, dementia, epilepsy, schizophrenia or history of psychosis, alcohol or substance abuse during last 6 months, current tic disorder, antisocial personality disorder, body dismorphic disorder, pregnancy, use of psychiatric medication other than stable use of one SSRI or clomipramine, one benzodiazepine, one atypical antipsychotic.

Outcomes

Primary Outcomes

Not specified

Similar Trials